Optiscan Imaging Ltd
Optiscan Imaging Ltd develops and commercializes medical imaging technologies, primarily focused on breast cancer detection using its proprietary optical imaging systems.
Business. Optiscan Imaging Ltd (OIL.AX) is a healthcare company specializing in advanced medical equipment and technology. The firm operates within the Healthcare Services & Equipment industry, focusing on the development and sale of healthcare equipment. Optiscan Imaging is headquartered in Australia and is primarily listed on the Australian Securities Exchange. Specific details regarding operating segments and geographic revenue mix are not available.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Optiscan Imaging Ltd (OIL.AX) is a healthcare company specializing in advanced medical equipment and technology. The firm operates within the Healthcare Services & Equipment industry, focusing on the development and sale of healthcare equipment. Optiscan Imaging is headquartered in Australia and is primarily listed on the Australian Securities Exchange. Specific details regarding operating segments and geographic revenue mix are not available.
Optiscan Imaging Ltd has a fully diluted share count of 1,044,176,632 shares, with no difference between basic and diluted shares outstanding, indicating no dilution risk from stock options or convertible securities. The company has not provided balance-sheet data or liquidity metrics, preventing a formal liquidity assessment. The lack of liquidity data combined with a negative EPS of -0.05 AUD suggests potential operational and financial challenges.
The company reported a loss per share of -0.05 AUD in its most recent earnings, indicating unprofitability. This performance is not benchmarkable against industry_config preferred metrics due to the absence of valuation_snapshot data. The lack of profitability metrics and the absence of ROIC or margin data prevent a direct comparison to cohort medians in the Advanced Medical Equipment & Technology industry.
Optiscan's revenue concentration and geographic exposure are not disclosed in the available data. The company does not provide segment-level revenue breakdowns or geographic revenue distribution, limiting visibility into its diversification strategy.
The company's growth trajectory is unclear due to the absence of revenue history and outlook data. No numeric deltas or forward-looking guidance is available to assess revenue or earnings momentum.
The risk assessment indicates low dilution potential, with no evidence of near-term share issuance or capital-raising activities. However, the absence of liquidity data and the negative EPS raise concerns about the company's ability to meet short-term obligations. No adjustments have been applied to valuation metrics due to the lack of financial inputs.
No recent events, such as filings or transcripts, are available in the source data to inform the company's current strategic or operational direction.
- Optiscan Imaging Ltd has no difference between basic and diluted shares outstanding, indicating no dilution risk from stock options or convertible securities.
- The company reported a loss per share of -0.05 AUD, suggesting unprofitability and financial challenges.
- No liquidity metrics or balance-sheet data is available, preventing a formal liquidity assessment.
- The company's revenue concentration, geographic exposure, and segment performance are not disclosed.
- No recent events or forward-looking guidance is available to assess the company's growth trajectory or strategic direction.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Revenue A$1.2M, −31,2% YoY; Operating income −39,3% YoY.
- ▍Revenue A$1.2M, −31,2% YoY
- ▍Operating income −39,3% YoY
- ▍Net income −39,3% YoY
- ▍Free cash flow −36,1% YoY
- ▍Net margin -524.4%
Revenue A$1.7M, +65,9% YoY; Operating income −2,8% YoY.
- ▍Revenue A$1.7M, +65,9% YoY
- ▍Operating income −2,8% YoY
- ▍Net income −2,8% YoY
- ▍Free cash flow +0,4% YoY
- ▍Net margin -259.0%
Revenue A$1.0M, +13,9% YoY; Operating income −102,8% YoY.
- ▍Revenue A$1.0M, +13,9% YoY
- ▍Operating income −102,8% YoY
- ▍Net income −99,0% YoY
- ▍Free cash flow −114,5% YoY
- ▍Net margin -417.9%
Revenue A$889.5k; Operating income -A$2.1M.
- ▍Revenue A$889.5k
- ▍Operating income -A$2.1M
- ▍Net margin -239.1%
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Optiscan Imaging Ltd Market data — financials · 2026-05-28
- Optiscan Imaging Ltd Market data — analyst estimates · 2026-05-28